Open AccessPilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis–related fatigue
Author(s) -
Kathryn C. Fitzgerald,
Bridget Morris,
Aurash Soroosh,
Alexandra Balshi,
Dermot P. Maher,
Adam I. Kaplin,
Bardia Nourbakhsh
Publication year - 2020
Publication title -
multiple sclerosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.729
H-Index - 131
eISSN - 1477-0970
pISSN - 1352-4585
DOI - 10.1177/1352458520936226
Subject(s) - medicine , tolerability , ketamine , placebo , multiple sclerosis , randomized controlled trial , anesthesia , confidence interval , adverse effect , alternative medicine , pathology , psychiatry
Fatigue is the most common symptom of MS and has no effective pharmacotherapy.